Is Losing Hair a Side Effect of Mounjaro?

The misconception worth clearing up first

The assumption many people arrive with is that Mounjaro is directly toxic to hair follicles. It is an understandable worry — you start a new medicine, you notice more hair in the shower, you connect the two. But the clinical picture is more nuanced. Hair loss does not appear in Mounjaro's listed common side effects on the NHS tirzepatide medicines page, and the Mounjaro SmPC on the eMC does not include alopecia as a frequently reported adverse reaction. What the SURMOUNT-1 trial data and real-world reporting both point toward is a pattern familiar to clinicians: telogen effluvium.

Telogen effluvium occurs when a physical stressor (surgery, illness, significant calorie restriction, or rapid weight change) pushes hair follicles from the growing (anagen) phase into the resting (telogen) phase simultaneously. About two to four months later, those follicles shed. The timing often coincides with the early weeks of treatment when weight loss is fastest, which is why the medicine looks like the cause. The mechanism is the weight loss, not tirzepatide's pharmacology. Our detailed piece on Mounjaro and hair loss unpacks this distinction if you want to go further.

A quick checking habit worth doing now: run your fingers gently through a small section of hair and count what comes away. Losing up to around 100 hairs a day is within the normal shedding range for most adults. If you are losing noticeably more than that in clumps, or you can see the scalp more clearly in certain areas, that is worth telling a clinician about, it takes under a minute and gives you a practical baseline to track.

What is actually driving the shedding

Tirzepatide works as a dual GIP and GLP-1 receptor agonist, slowing gastric emptying and reducing appetite, which leads to a significant calorie deficit for most people. When total calorie intake falls sharply, protein and micronutrient availability for hair follicles often falls with it. Hair is metabolically expensive tissue, the body will deprioritise follicle maintenance when resources are scarce.

Low protein intake is the most commonly implicated nutritional factor. If someone is eating less and not paying attention to protein quality, hair follicles can enter the shedding cycle faster. Iron, zinc and B vitamins are secondary factors worth keeping an eye on. None of this means you should eat more than your body is asking for, but it does mean the composition of what you eat during treatment matters. The NHS guidance on healthy weight and diet is a reasonable starting framework, though a prescriber or dietitian can give advice specific to your plan.

You can read more about the broader side-effect profile of tirzepatide across our overview of Mounjaro side effects, which covers the GI effects that get more attention alongside rarer reports. The wider GLP-1 and tirzepatide side-effect page also places these patterns in context across the medicine class.

When hair shedding needs medical attention

Most telogen effluvium resolves on its own. Shedding typically peaks around three to four months after the triggering event, then gradually tapers as the follicle cycle resets. That said, there are situations where hair loss during or after Mounjaro treatment needs a proper clinical review rather than reassurance.

See your GP if you notice patchy or sudden loss in specific areas (which can indicate alopecia areata, an autoimmune condition unrelated to weight loss), if the shedding is accompanied by other symptoms like fatigue, cold sensitivity or irregular periods (which might suggest thyroid involvement), or if significant hair loss continues for more than six months without improvement. A blood test to check thyroid function, ferritin, vitamin D and protein markers is straightforward and can rule out treatable causes quickly.

Mounjaro is a prescription-only medicine, and the full side-effect guidance that prescribers work from is specific about which symptoms need same-day urgent care and which can be monitored. If you develop symptoms that concern you during treatment, you can also contact our aftercare team, who are available seven days a week. Suspected adverse reactions can be reported directly through the MHRA Yellow Card scheme, which helps regulators track real-world safety signals across all medicines.

What a prescriber looks at during your consultation

At nume, every consultation is reviewed by a GPhC-registered prescriber, a real clinician reading your answers, not a form-sorting algorithm. Before any treatment is approved, the prescriber looks at your full health picture, including any existing conditions that might affect hair health, your current medications, and factors that could influence how well you tolerate a significant calorie reduction.

If you are already on Mounjaro and worried about hair changes, the aftercare model means you are not left to figure it out alone. Side effects and how to manage them are part of what our clinical team is there for. For anyone weighing up whether to start, the Mounjaro treatment page covers how the medicine works and what to expect, and our frequently asked questions address common concerns across the treatment journey. Pricing, if that is part of your decision, is covered clearly on the Mounjaro prices page. The right starting point is the same either way: a free, thorough consultation through our treatment page. Our prescribers discuss suitability, anticipated side effects, and your individual circumstances before anything is prescribed.